MDXG
Mimedx Group Inc

4,776
Loading...
Loading...
News
all
press releases
MiMedx (MDXG) Q2 Earnings and Revenues Beat Estimates
MiMedx (MDXG) delivered earnings and revenue surprises of +66.67% and +10.45%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?
Zacks·2mo ago
News Placeholder
More News
News Placeholder
MiMedx and Organogenesis stocks tumble after CMS proposal to slash spending
Investing.com -- MiMedx Group (NASDAQ:MDXG) stock fell 19% and Organogenesis Holdings (NASDAQ:ORGO) shares plunged 36% after the Centers for Medicare&Medicaid Services (CMS) proposed a rule that would drastically cut Medicare spending on skin substitutes.
investing.com·3mo ago
News Placeholder
Strength Seen in MiMedx (MDXG): Can Its 8.0% Jump Turn into More Strength?
MiMedx (MDXG) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price increase in the near term.
Zacks·3mo ago
News Placeholder
EX-MiMEDX EMPLOYEES ALLEGE MiMEDX "PRESSURE[D] HEALTHCARE PROVIDERS TO TREAT WOUNDED VETERANS, DIABETICS, CHRONIC WOUND SUFFERERS, AND OTHER PATIENTS WITH MEDICALLY UNNECESSARY OR UNSUITABLE PRODUCTS"
EX-MiMEDX EMPLOYEES ALLEGE MiMEDX 'PRESSURE[D] HEALTHCARE PROVIDERS TO TREAT WOUNDED VETERANS, DIABETICS, CHRONIC WOUND SUFFERERS, AND OTHER PATIENTS WITH MEDICALLY UNNECESSARY OR UNSUITABLE...
PR Newswire·1y ago
News Placeholder
THIRD DEFENDANT FIGHTS BACK AGAINST MiMEDX, CLAIMING 'DISREPUTABLE AND UNLAWFUL BUSINESS PRACTICES'
THIRD DEFENDANT FIGHTS BACK AGAINST MiMEDX, CLAIMING 'DISREPUTABLE AND UNLAWFUL BUSINESS PRACTICES' THIRD DEFENDANT FIGHTS BACK AGAINST MiMEDX, CLAIMING 'DISREPUTABLE AND UNLAWFUL BUSINESS PRACTICES...
PR Newswire·1y ago
News Placeholder
DEFENDANT FIGHTS BACK AGAINST MiMEDX "BLATANT INTIMIDATION" NON-COMPETE SUIT
DEFENDANT FIGHTS BACK AGAINST MiMEDX 'BLATANT INTIMIDATION' NON-COMPETE SUIT DEFENDANT FIGHTS BACK AGAINST MiMEDX 'BLATANT INTIMIDATION' NON-COMPETE SUIT PR Newswire MARIETTA, Ga., Aug. 26, 2024...
PR Newswire·1y ago
News Placeholder
Craig-Hallum Sticks to Its Buy Rating for MiMedx Group (MDXG)
Craig-Hallum analyst Chase Knickerbocker maintained a Buy rating on MiMedx Group (MDXG Research Report) today. The company's shares closed yester...
TipRanks Financial Blog·1y ago
News Placeholder
MIMEDX Provides Update on AXIOFILL Request for Designation ( RFD ) from FDA
Receives Determination Letter from FDA Stating AXIOFILL Does Not Qualify for Classification as an HCT/P Under Section 361 MIMEDX Continues to Pursue All Available Options to Keep AXIOFILL on the...
Globe Newswire·2y ago
News Placeholder
MiMedx Group (MDXG, $7.83) Moving Average Convergence Divergence (MACD) Histogram turned negative on March 25, 2024
This is a Bearish indicator signaling MDXG's price could decline from here. Traders may explore shorting the stock or put options...
Tickeron - Technical Analysis·2y ago
News Placeholder
MiMedx Group (MDXG, $8.03) entered Downtrend as Momentum indicator drops below 0 level on Mar 22, 2024
This indicator may be signaling that MDXG's price has further to drop, since it moved below its price 14 days ago. Traders may consider selling the stock, shorting the stock, or exploring put options...
Tickeron - Stocks·2y ago

Latest MDXG News

View

Advertisement|Remove ads.

Advertisement|Remove ads.